Wolfe Research Downgrades Inspire Medical Systems (INSP) to Peerperform

Wolfe Research analyst Mike Polark downgraded Inspire Medical Systems (NYSE: INSP) from Outperform to Peerperform.

The analyst commented: "This was a swing from us & complete miss. Feel dumb & slightly angry (at ourselves/CMS). Sigh. It’s cheap but believing with conviction the lowered guide is difficult given reduced doctor incentive. And ahead things get trickier. I.e., GLP-1s, NYXH, LIVN, Apnimed."

For an analyst ratings summary and ratings history on Inspire Medical Systems click here. For more ratings news on Inspire Medical Systems click here.

Shares of Inspire Medical Systems closed at $59.65 yesterday.

You May Also Be Interested In

• Wizz Air Holdings (WIZZ:LN) (WZZAF) PT Raised to GBP14 at Bernstein SocGen Group
• S&P Global (SPGI) PT Lowered to $510 at RBC Capital Following Mobility Spin
• Piper Sandler Reiterates Overweight Rating on Viking Therapeutic (VKTX)